Abbio XR Revenue
Biotechnology Research • 
United States • 1-10 Employees
$
Abbio XR revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Abbio XR
Seth Flatt
Co-Founder & Chief Executive Officer
Company overview
| Headquarters | United States |
| Phone number | +15746122214 |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
About Abbio XR
Abbio XR is dedicated to transforming peptide therapeutics with our extended release platform technology. Our mission is to reduce adverse effects and remove the need for frequent GLP-1 dosing, making it possible to administer treatments every three months rather than weekly.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Abbio XR has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Abbio XR has never raised funding before.
Ireland
Czechia
Frequently asked questions
Abbio XR is located in US.
You can reach Abbio XR at +15746122214.
Abbio XR generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
Abbio XR has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Abbio XR was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
Abbio XR has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
